Gut Health: When diet meets genetics
Gene expression profiling of a diverse mouse population helps to decipher how a fat-rich diet contributes to inflammatory bowel disease.
- Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, United States
Inflammatory bowel disease (IBD) encompasses a group of conditions – including ulcerative colitis and Crohn’s disease – characterized by chronic gut inflammation. Quality of life can be significantly negatively impacted by these conditions, and they can also increase the risk of colorectal cancer. How and why IBD emerges remains poorly understood.
Our digestive system constantly adapts to what we eat, with different foods triggering changes to the way our gut cells express their genes. Factors like diet, genetics and the environment can all play a role in causing gut inflammation, which can become chronic and result in damage (Huang et al., 2017; Enriquez et al., 2022). In particular, the global rise in IBD incidence has been partly linked to increased consumption of fat-rich diets (Maconi et al., 2010; Hou et al., 2011). However, while studies in mice have shown that such diets can increase gut inflammation (Wang et al., 2023), in humans the effects vary among individuals (Zeevi et al., 2015). Understanding how genes and diet interact during early gut inflammation is therefore crucial to understand how IBD starts and to pinpoint the genes involved. It can be difficult to conduct this work due to the wide genetic diversity among humans and the challenges of creating controlled environments to study them in.
Systems genetics is an approach that allows scientists to dissect how various environmental and genetic factors work together to influence disease susceptibility and other traits (Seldin et al., 2019). It relies on ‘libraries’ of mice strains, such as the BXD recombinant inbred family, which have been created to have well-documented genetic differences (Ashbrook et al., 2021). By exposing this ‘genetic reference population’ to various controlled settings, it becomes possible to precisely examine interactions between genes and the environment.
Now, in eLife, Maroun Sleiman, Johan Auwerx of the École Polytechnique Fédérale de Lausanne and colleagues – including Xiaoxu Li as first author – report that a systems genetics approach to studying the relationship between a fat-rich diet and gut inflammation can identify candidate genes that might influence susceptibility to IBD in humans (Li et al., 2023).
First, Li et al. fed 52 BXD mouse strains with either a regular or fat-rich diet. Analyzing the gene expression profiles of the mice guts showed that overall, the fat-rich diet led to increased expression of genes involved in inflammatory pathways. However, much like in humans, the mice strains displayed diverse gene expression profiles. In fact, several strains were resistant to dietary changes, demonstrating that genetic differences can override the effect of diet.
Next, Li et al. compared the gene expression profiles of the BXD mice fed the fat-rich diet with existing datasets from mice and humans with IBD. On average, the genes dysregulated in IBD and in BXD mice were the same, indicating that the fat-rich diet had led to IBD-like gut inflammation. Individually, the gene expression of each strain could be used to classify the strain as as ‘susceptible’, ‘intermediate’, or ‘resistant’ to IBD-like inflammation.
Finally, network modelling approaches were used to group genes that are co-expressed or tend to work together in BXD mice. In animals fed fat-rich diets, some of the resulting ‘modules’ were enriched with genes that are dysregulated in IBD, with two containing genes involved in regulating gut inflammation. Li et al. then used three criteria to identify genes within the modules that might be key to IBD inflammation. Based on the existing human datasets, genetic variants of two of the genes that met these criteria – Epha6 and Muc4 – are also associated with ulcerative colitis, suggesting they could be key to regulating gut inflammation (Figure 1).
Figure 1
A systems genetics approach to identifying genes involved in diet-related gut inflammation.
A diverse group of 52 BXD mouse strains were exposed to regular (chow) or fat-rich diets. Their guts were then collected and gene expression was measured. Further network modeling analyses revealed that the fat-rich diet led to gut inflammation gene expression profiles similar to those in existing, published mouse and human IBD datasets and identified two modules of interest (Modules A and D). Within module D, two genes (Muc4 and Epha6) were identified as candidates that may control gut inflammation in IBD as their genetic variants were also associated with ulcerative colitis in humans. IBD, Inflammatory Bowel Disease.
Image credit: Figure created using BioRender.
The findings, obtained using a powerful combination of systems genetics and pre-published datasets, help to shed light on how genetic makeup and diet dictate vulnerability to IBD. The work also provides a dataset that can be used to generate new ideas for future research, which is important for developing better preventive and treatment strategies for gut-related inflammatory disorders. It also remains to be seen whether the candidate genes identified using this approach can be used to manipulate vulnerability to gut inflammation.
References
-
Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literatureAmerican Journal of Gastroenterology 106:563–573.https://doi.org/10.1038/ajg.2011.44
-
Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control studyWorld Journal of Gastroenterology 16:4297–4304.https://doi.org/10.3748/wjg.v16.i34.4297
-
Systems genetics applications in metabolism researchNature Metabolism 1:1038–1050.https://doi.org/10.1038/s42255-019-0132-x
-
Intestinal cell type-specific communication networks underlie homeostasis and response to Western dietThe Journal of Experimental Medicine 220:e20221437.https://doi.org/10.1084/jem.20221437
Article and author information
Author details
Karthickeyan Chella Krishnan
Publication history
Copyright
© 2023, Chella Krishnan
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 856
- views
-
- 82
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Gut Health: When diet meets genetics
eLife 12:e92714.
https://doi.org/10.7554/eLife.92714
Further reading
-
- Computational and Systems Biology
- Developmental Biology
The Notch signaling pathway uses families of ligands and receptors to transmit signals to nearby cells. These components are expressed in diverse combinations in different cell types, interact in a many-to-many fashion, both within the same cell (in cis) and between cells (in trans), and their interactions are modulated by Fringe glycosyltransferases. A fundamental question is how the strength of Notch signaling depends on which pathway components are expressed, at what levels, and in which cells. Here, we used a quantitative, bottom-up, cell-based approach to systematically characterize trans-activation, cis-inhibition, and cis-activation signaling efficiencies across a range of ligand and Fringe expression levels in Chinese hamster and mouse cell lines. Each ligand (Dll1, Dll4, Jag1, and Jag2) and receptor variant (Notch1 and Notch2) analyzed here exhibited a unique profile of interactions, Fringe dependence, and signaling outcomes. All four ligands were able to bind receptors in cis and in trans, and all ligands trans-activated both receptors, although Jag1-Notch1 signaling was substantially weaker than other ligand-receptor combinations. Cis-interactions were predominantly inhibitory, with the exception of the Dll1- and Dll4-Notch2 pairs, which exhibited cis-activation stronger than trans-activation. Lfng strengthened Delta-mediated trans-activation and weakened Jagged-mediated trans-activation for both receptors. Finally, cis-ligands showed diverse cis-inhibition strengths, which depended on the identity of the trans-ligand as well as the receptor. The map of receptor-ligand-Fringe interaction outcomes revealed here should help guide rational perturbation and control of the Notch pathway.
-
- Computational and Systems Biology
- Evolutionary Biology
As pathogens spread in a population of hosts, immunity is built up, and the pool of susceptible individuals are depleted. This generates selective pressure, to which many human RNA viruses, such as influenza virus or SARS-CoV-2, respond with rapid antigenic evolution and frequent emergence of immune evasive variants. However, the host’s immune systems adapt, and older immune responses wane, such that escape variants only enjoy a growth advantage for a limited time. If variant growth dynamics and reshaping of host-immunity operate on comparable time scales, viral adaptation is determined by eco-evolutionary interactions that are not captured by models of rapid evolution in a fixed environment. Here, we use a Susceptible/Infected model to describe the interaction between an evolving viral population in a dynamic but immunologically diverse host population. We show that depending on strain cross-immunity, heterogeneity of the host population, and durability of immune responses, escape variants initially grow exponentially, but lose their growth advantage before reaching high frequencies. Their subsequent dynamics follows an anomalous random walk determined by future escape variants and results in variant trajectories that are unpredictable. This model can explain the apparent contradiction between the clearly adaptive nature of antigenic evolution and the quasi-neutral dynamics of high-frequency variants observed for influenza viruses.
